|Articles|November 1, 2003
- Pharmaceutical Technology-11-01-2003
- Volume 2003 Supplement
- Issue 5
21 CFR Part 11: Where Are We Now?
Author(s)William Goebel
FDA's revised guidance on 21 CFR Part 11 offers relief to the regulated industry by providing for enforcement discretion and suggesting a risk-based approach to compliance.
Advertisement
Articles in this issue
almost 23 years ago
Improving the Management of Batch Recordsalmost 23 years ago
Understanding Data, Symbol, and Technology Optionsalmost 23 years ago
Web Services in Pharmaceutical Manufacturingalmost 23 years ago
Integrated Compliance ManagementAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Technology Transfer: Success Drivers and Obstacles Explained
2
Shilpa CDMO to Launch as Dedicated Complex Small-Molecule Contract Development and Manufacturing Brand at CPHI Milan
3
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
4
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
5